產品名稱 |
Influenza A virus (H3N2) |
商品貨號 |
B162828 |
Classification |
Orthomyxoviridae, Alphainfluenzavirus |
Agent |
Influenza A virus (H3N2) |
Strain |
A/Wisconsin/67/2005 (H3N2) |
Applications |
Respiratory pathogen research
Vaccine research |
Biosafety Level |
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Product Format |
frozen 0.5 mL per vial |
Storage Conditions |
-70°C or colder |
Comments |
The US Food and Drug Administration recommended Influenza A/Wisconsin/67/2005 (H3N2)-like viruses for use as vaccines during the 2006-2007 and 2007-2008 Influenza seasons. The World Health Organization recommended Influenza A/Wisconsin/67/2005 (H3N2)-like viruses for use as vaccines during the 2007 Southern Hemisphere Influenza season. |
Effect on Host |
Hemagglutinates chicken RBC |
Recommended Host |
SPF chicken embryonated eggs, 9-11 days |
Growth Conditions |
Temperature: 33°C
Recommendations for Infection: Inoculate SPF chicken embryonated eggs (intra-allantoic) at 9- to 11-days-old. Dilute virus in D-PBS prior to inoculation.
Incubation: 2 days at 33°C in a humidified, non-CO2 atmosphere. |
Name of Depositor |
P Shult, Wisconsin State Laboratory of Hygiene |
Source |
Isolated from a human in Wisconsin, USA on August 31, 2005. |
References |
Advisory Committee on Immunization Practices, et al. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55(R-10): 1-42, 2006. PubMed: 16874296
Fiore AE, et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 56(RR-6): 1-54, 2007. PubMed: 17625497
|